dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Farinango, Camila |
dc.contributor.author | Gallardo-Cóndor, Jennifer |
dc.contributor.author | Freire Paspuel, Byron |
dc.contributor.author | Flores-Espinoza, Rodrigo |
dc.contributor.author | Jaramillo-Koupermann, Gabriela |
dc.contributor.author | López-Cortés, Andrés |
dc.date.accessioned | 2022-09-12T09:35:15Z |
dc.date.available | 2022-09-12T09:35:15Z |
dc.date.issued | 2022-06-10 |
dc.identifier.citation | Farinango C, Gallardo-Cóndor J, Freire-Paspuel B, Flores-Espinoza R, Jaramillo-Koupermann G, López-Cortés A, et al. Genetic Variations of the DPYD Gene and Its Relationship with Ancestry Proportions in Different Ecuadorian Trihybrid Populations. J Pers Med. 2022 Jun 10;12(6):950. |
dc.identifier.issn | 2075-4426 |
dc.identifier.uri | https://hdl.handle.net/11351/8149 |
dc.description | Ètnies equatorianes; Fluoropirimidines; Farmacogenètica |
dc.description.sponsorship | This work was supported by Universidad de Las Américas (Quito, Ecuador), grant number ENF.RCA.19.01. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Journal of Personalized Medicine;12(6) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Tractament |
dc.subject | Antimetabòlits - Efectes secundaris |
dc.subject | Genètica |
dc.subject.mesh | Antimetabolites, Antineoplastic |
dc.subject.mesh | /adverse effects |
dc.subject.mesh | Genetic Variation |
dc.subject.mesh | Neoplasms |
dc.title | Genetic Variations of the DPYD Gene and Its Relationship with Ancestry Proportions in Different Ecuadorian Trihybrid Populations |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/jpm12060950 |
dc.subject.decs | antimetabolitos antineoplásicos |
dc.subject.decs | /efectos adversos |
dc.subject.decs | variación genética |
dc.subject.decs | neoplasias |
dc.relation.publishversion | https://doi.org/10.3390/jpm12060950 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Farinango C, Gallardo-Cóndor J] Facultad de Ingeniería y Ciencias Aplicadas, Universidad de Las Américas, Quito, Ecuador. [Freire-Paspuel B] Laboratorios de Investigación, Universidad de Las Américas, Quito, Ecuador. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Flores-Espinoza R] Laboratorios de Investigación, Universidad de Las Américas, Quito, Ecuador. Laboratório de Diagnóstico por DNA (LDD), Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil. [Jaramillo-Koupermann G] Laboratorio de Biología Molecular, Subproceso de Anatomía Patológica, Hospital de Especialidades Eugenio Espejo, Quito, Ecuador. [López-Cortés A] Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad de Las Américas, Quito, Ecuador. Programa de Investigación en Salud Global, Facultad de Ciencias de la Salud, Universidad Internacional SEK, Quito, Ecuador. Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain |
dc.identifier.pmid | 35743735 |
dc.identifier.wos | 000816343500001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |